MiR-124-3p.1 regulates the PTM of FOXO3a by simultaneously targeting AKT2 and SIRT1, a coordinate regulation mode that results in sensitization of HCC to sorafenib, thus, providing a new target to reduce resistance to sorafenib in HCC. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.